Abstract:H earing loss is a very common congenital disorder affecting one in 1000 newborns. More than 50% of deafness cases in the paediatric population have a genetic cause with autosomal dominant, autosomal recessive, X-linked, or mitochondrial patterns of inheritance. Mutations in mitochondrial DNA (mtDNA), particularly in the 12S rRNA and tRNA genes, have been found to be one of the most important causes of sensorineural hearing loss (SNHL). 3 The homoplasmic A1555G mutation in the highly conserved decoding site of the mitochondrial 12S rRNA has been found to be associated with both aminoglycoside-induced and non-syndromic SNHL in many families of different ethnic origins. Recently, the homoplasmic C1494T mutation in the same gene has also been found to be associated with aminoglycoside-induced and non-syndromic SNHL in a large Chinese family. In addition, a C-insertion or deletion at position 961 of the 12S rRNA gene has been shown to be associated only with aminoglycoside-induced deafness. 11 Furthermore, the mitochondrial tRNA appears to be another hot spot for mutations associated with hearing impairment, as five deafness-associated mutations have been identified in the mitochondrial tRNA gene: A7445G, 13 7472insC, T7510C, T7511C, and T7512C. However, non-syndromic deafness-associated mtDNA mutations, such as the A1555G or A7445G mutation, are often not sufficient to produce the clinical phenotype since some individuals carrying these mutations have normal hearing. Thus, other factors including other mtDNA mutations/polymorphisms and/or nuclear backgrounds or environmental factors modulate the phenotypic variability and penetrance of deafness associated with these mtDNA mutations. However, little is known about the incidence of these deafness-associated mtDNA mutations. Furthermore, it is anticipated that additional deafness-associated mutations will be found in the 12S rRNA and tRNA genes. A retrospective database review of all children with SNHL and subsequent molecular analysis has been initiated in the clinical population at the Center for Hearing and Deafness Research (CHDR) at the Cincinnati Children’s Hospital Medical Center (CCHMC). In the present study, a mutational analysis of the 12S rRNA and tRNA genes was performed in 164 SNHL subjects from this clinic and 226 unaffected individuals from a comparable ethnic background. This analysis led to the identification of 17 nucleotide changes including the novel G to T transversion at position 961 (T961G) in the 12S rRNA gene in five affected subjects. To elucidate the molecular basis for the T961G mutation, we completed the mitochondrial genome sequence from these five affected subjects. To examine the role of the GJB2 gene in the phenotypic expression of the known or putative deafness-associated mtDNA mutations, we also performed mutational screening of the GJB2 gene in subjects carrying the mtDNA mutations.

Original Article Prevalence of P.v37i Variant of GJB2 among Chinese Infants with Mild or Moderate Hearing Loss

GJB2 Mutation Spectrum and Genotype-Phenotype Correlation in 1067 Han Chinese Subjects with Non-Syndromic Hearing Loss

The Homozygote P.v27i/p.e114g Variant of GJB2 is a Putative Indicator of Nonsyndromic Hearing Loss in Chinese Infants

Mutation Analysis of GJB2 Gene in 1 822 Patients with Nonsyndromic Hearing Loss in Zhejiang Province

Analysis of Genotype-Phenotype Correlation for GJB2 in 221 Non-Syndromic Deafness Probands and Their Pedigrees

[Spectrum of GJB6 Variants in 318 Pedigrees with Non-Syndromic Hearing Loss:One Deafness Pedigree Carrying Both GJB6 and GJB2 Deletion Variant].

The Homozygous P.v37i Variant of GJB2 is Associated with Diverse Hearing Phenotypes.

Molecular analysis of the mitochondrial 12S rRNA and tRNASer(UCN) genes in paediatric subjects with non-syndromic hearing loss.

Prevalence of Common Genetic Mutations and Clinical Characteristics Analysis in Patients at Different Ages with Nonsyndromic Hearing Impairment

Prevalence and range of GJB2 and SLC26A4 mutations in patients with autosomal recessive non‑syndromic hearing loss.

The p.V37I Exclusive Genotype Of GJB2: A Genetic Risk-Indicator of Postnatal Permanent Childhood Hearing Impairment

Biallelic p.V37I variant in GJB2 is associated with increasing incidence of hearing loss with age

Prevalence of GJB2 Gene Mutation in 330 Cochlear Implant Patients in the Jiangsu Province

The prevalence of the 235delC GJB2 mutation in a Chinese deaf population

Prevalence of mutations in GJB2, SLC26A4, and mtDNA in children with severe or profound sensorineural hearing loss in southwestern China

A Novel Compound Heterozygous Mutation In The Gjb2 Gene Causing Non-Syndromic Hearing Loss In A Family

Carrier frequencies, trends, and geographical distribution of hearing loss variants in China: The pooled analysis of 2,161,984 newborns

GJB2 mutation analysis for 55 patients with nonsyndromic hearing impairment

Unveiling a Novel GJB2 Dominant K22T Mutation in a Chinese Family with Hearing Loss.

Molecular Epidemiology of Chinese Han Deaf Patients with Bi-Allelic and Mono-Allelic GJB2 Mutations

Analysis of mitochondrial tRNAHis12192G> A mutation in a pedigrees with non-syndromic hearing loss